CXCR4 and neoplasm: In lung cancer, in particular, several studies have demonstrated a correlation between CXCR4 expression and clinical outcomes, with increased expression in tumor tissue over normal lung tissue, and increased expression in tumors of patients with metastatic disease versus those without clinical metastasis [61–69].